Singapore Markets close in 3 hrs 47 mins

Galena Biopharma, Inc. (GALE)


NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.5983+0.01 (+1.94%)
At close: 4:00PM EDT
People also watch
IMUCCYTRINOCLDXTHLD
Full screen
Previous close0.5869
Open0.5900
Bid0.0000 x
Ask0.0000 x
Day's range0.5800 - 0.6200
52-week range0.1600 - 4.7500
Volume656,770
Avg. volume716,257
Market cap22.4M
Beta2.19
PE ratio (TTM)-0.46
EPS (TTM)-1.31
Earnings date7 Aug 2017 - 11 Aug 2017
Dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.00
Trade prices are not sourced from all markets
  • AbbVie and J&J Present Positive Imbruvica Leukemia Data
    Zackslast month

    AbbVie and J&J Present Positive Imbruvica Leukemia Data

    AbbVie Inc. (ABBV) recently announced positive data from a pooled analysis of three phase III studies evaluating its cancer drug, Imbruvica (ibrutinib).

  • Associated Press2 months ago

    Galena Biopharma reports 1Q loss

    On a per-share basis, the San Ramon, California-based company said it had a loss of 45 cents. Losses, adjusted to account for discontinued operations, came to 9 cents per share. In the final minutes of ...

  • Associated Press2 months ago

    Galena Biopharma reports 1Q loss

    On a per-share basis, the San Ramon, California-based company said it had a loss of 45 cents. Losses, adjusted to account for discontinued operations, came to 9 cents per share. In the final minutes of ...